| Product NDC: | 68012-258 |
| Proprietary Name: | CYCLOSET |
| Non Proprietary Name: | bromocriptine mesylate |
| Active Ingredient(s): | .8 mg/1 & nbsp; bromocriptine mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68012-258 |
| Labeler Name: | Santarus, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020866 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101115 |
| Package NDC: | 68012-258-60 |
| Package Description: | 600 TABLET in 1 BOTTLE (68012-258-60) |
| NDC Code | 68012-258-60 |
| Proprietary Name | CYCLOSET |
| Package Description | 600 TABLET in 1 BOTTLE (68012-258-60) |
| Product NDC | 68012-258 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | bromocriptine mesylate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101115 |
| Marketing Category Name | NDA |
| Labeler Name | Santarus, Inc. |
| Substance Name | BROMOCRIPTINE MESYLATE |
| Strength Number | .8 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |